Studies on the metabolic fate of valproic acid in the rat using stable isotope techniques
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 17 (10) , 1147-1157
- https://doi.org/10.3109/00498258709167407
Abstract
1. The metabolic fate of two specifically deuterated analogues of valproic acid (VPA), [2-2H1]VPA and [3,3-2H2]VPA, was studied in the rat following i.p. injection. 2. A total of 11 urinary metabolites of each labelled substrate were detected by g.l.c.-mass spectrometry. Those metabolites which resulted from oxidation of the drug at C-4 and/or C-5 retained the deuterium label(s), whereas products of oxidation at C-2 and/or C-3 exhibited varying degrees of deuterium loss. 3. The deuterium content of 3-hydroxy-VPA indicated that this metabolite has a dual origin, and arises in part by β-oxidation of VPA and in part by direct hydroxylation at C-3. An apparent intramolecular isotope effect (kH/kD) of ca. 8 was associated with the latter process. 3-Oxo-VPA appeared to be formed mainly by oxidation of Δ2-VPA, rather than by oxidation of 3-hydroxy-VPA. 4. Evidence was obtained that Δ3-VPA is formed reversibly from Δ2-VPA, and that further desaturation of Δ3-VPA gives rise to a metabolite believed to have a 2,3′-diene structure. 5. The stable isotope method employed in this investigation represents a powerful technique for studies on the origin of drug metabolites and for the elucidation of complex metabolic inter-relationships in vivo.This publication has 22 references indexed in Scilit:
- Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acidBiochemical and Biophysical Research Communications, 1985
- A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significanceLife Sciences, 1985
- Metabolism of valproic acid by hepatic microsomal cytochrome P-450Biochemical and Biophysical Research Communications, 1984
- Valproate–Induced Hepatic Steatogenesis in RatsHepatology, 1982
- INHIBITION OF FATTY ACID OXIDATION BY VALPROATEThe Lancet, 1980
- The occurrence of C6–C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetateBiochemical Medicine, 1980
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediateBiochemical and Biophysical Research Communications, 1978
- Intramolecular determination of primary kinetic isotope effects in hydroxylations catalyzed by cytochrome P-450Biochemical and Biophysical Research Communications, 1977
- Metabolism of branched medium chain length fatty acid. II—β-oxidation of sodium dipropylacetate in ratsJournal of Mass Spectrometry, 1976